NBC I BioAgilytix

National Biotechnology Conference

April 23-26
10:00 a.m - 6:00 p.m PT
Marriott Downtown, Philadelphia, PA 19107

We look forward to meeting with you at NBC.

Request a meeting with our scientific experts in Philadelphia, booth #916, to learn how we help our clients advance their drug modality.

Schedule a Meeting

Speak with our scientific experts onsite to discuss your project.

I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

BioAgilytix Presentations at NBC

Hot Topic Panel Presentations:

Intro to Biomarkers: An Expert Panel Discussion

Panelist: Amanda Hays, PhD
Tuesday, April 25th
3:00 p.m – 4:00 p.m

Rapid Fire Presentations:

Considerations for Developing and Validating an Anti-AAV9 ADA Assay

Presenter: Sara Alhakeem, PhD
Monday, April 24th
2:45 p.m. – 3:00 p.m

qPCR Biodistribution and Shedding Assessment Strategy in Gene Therapy Studies

Presenter: Amanda Hays, PhD
Monday, April 24th
3:15 p.m – 3:30 p.m

Challenges in Developing Robust Hybridization Immunoassays

Presenter: Liz Nolff, MS
Wednesday, April 26th
2:45 p.m – 3:00 p.m

Poster Presentations:

Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay
to Quantify an Allogeneic Cell Product in Human Blood by ddPCR

Presenter: Brian D. Bower, PhD
Submission ID# 1452441


Accurately measure the immunogenicity and pharmacokinetics (PK) of your biotherapeutics and advanced modalities

We provide the global, best-in-class bioanalytical capabilities needed to address even the most challenging biomarker, immunogenicity, PK, and cell-based assay requirements.


Detect your drug product or it’s downstream effects with an experienced molecular assay partner

We have a proven track record working with biotherapeutics and advanced modalities. We have been successfully supporting these programs across a variety of delivery mechanisms and matrices for over 10 years.


Rely on services backed by global good manufacturing practices (GMP)

We offer a full suite of bioanalytical lifecycle services supporting the release, production, and manufacturing of therapeutic drugs. Our GMP-driven service offerings include immunoassays, cell-based assays, and molecular assays for potency assessments.


Access our vast biomarker experience to better understand the PD of your therapeutic

We offer a wide variety of off-the-shelf biomarker assays, including 120+ validated biomarker assays for a range of disease states.

Speak with our team about how the combination of world-class scientific expertise, outstanding project management, and superior regulatory insight can expedite your advanced therapeutic. You can also fill out the form, and an expert will reach out to schedule a meeting with you onsite.